Search

Home > Lung Cancer Considered > FDA Approval Zenocutuzumab For NRG1 Fusion Cancers
Podcast: Lung Cancer Considered
Episode:

FDA Approval Zenocutuzumab For NRG1 Fusion Cancers
Category: Science & Medicine
Duration: 00:20:29
Publish Date: 2025-01-21 14:00:16
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1 fusions are rare but important events seen in many cancer types, including NSCLC. Zenocutuzumab is a HER2/HER3 bispecific antibody that showed clear efficacy in NSCLC and in pancreatic cancer that harbored an NRG1 fusion. Guest: Dr. Alison Schram, Assistant Attending Physician and Section Head of Oral Therapeutics in Early Drug Development at Memorial Sloan Kettering Cancer Center in New York
Total Play: 0